IDEXX Laboratories, Inc.
IDXX
$411.49
$9.112.26%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.17% | 14.53% | -13.70% | 21.11% | -8.34% |
| Total Depreciation and Amortization | -1.25% | 6.03% | 7.65% | 0.56% | 2.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 99.61% | 817.33% | -110.06% | 189.45% | -207.07% |
| Change in Net Operating Assets | 84.77% | -501.71% | 117.54% | -294.67% | 160.45% |
| Cash from Operations | 19.06% | -11.37% | 25.04% | -20.52% | -8.29% |
| Capital Expenditure | -4.15% | 15.66% | -10.02% | 7.01% | 4.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | -- | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,651.33% | 4.27% | 20.97% | -84.49% | -66.10% |
| Cash from Investing | -45.58% | 16.83% | 69.23% | -251.38% | -9.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -513.75% |
| Issuance of Common Stock | 165.31% | -6.83% | -74.32% | 84.28% | -10.21% |
| Repurchase of Common Stock | -11.34% | -2.49% | -30.70% | -346.81% | -4.58% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 84.56% |
| Cash from Financing | 20.00% | -38.40% | -45.92% | -41.47% | -136.64% |
| Foreign Exchange rate Adjustments | -283.85% | 626.14% | 75.16% | -187.18% | 272.80% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 78.09% | -2,336.08% | 107.36% | -146.22% | -38.53% |